TrialBreast cancer (Tokyo, Japan)2017

Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.

Manabu Futamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.